Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding mRNA vaccines, despite real-world evidence ...

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced ...

The US Department of Health and Human Services is terminating a contract with drugmaker Moderna to develop a vaccine to protect against bird flu amid the agency’s broader efforts to reevaluate ...

THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a vaccine for bird flu and other dangerous flu strains, raising ...

Bird Flu Threat Still Looms, But HHS Just Canceled a Moderna Contract That Could Prepare for It ... and Moderna’s vaccine candidate for avian influenza is on track for Phase 3 testing.

The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an mRNA vaccine for flu strains with pandemic potential, including bird flu.

A veterinarian vaccinates an Egyptian vulture against avian influenza at the Mulhouse zoo, eastern France, in 2020. Moderna had been developing a vaccine to combat an outbreak of bird flu in dairy ...

Moderna’s clinical study was focused on using mRNA to boost human immunity to the bird flu, which has devastated egg-laying hens but is low risk at the moment to humans. The bird flu outbreak ...

The Trump administration has terminated a multi-million-dollar contract with Massachusetts-based Moderna to support its late-stage development of a bird flu vaccine for humans. The company ...